Literature DB >> 12622657

Compounded brain volume deficits in schizophrenia-alcoholism comorbidity.

Daniel H Mathalon1, Adolf Pfefferbaum, Kelvin O Lim, Margaret J Rosenbloom, Edith V Sullivan.   

Abstract

BACKGROUND: Schizophrenia and alcoholism are characterized by brain volume abnormalities. Despite the frequent comorbidity of these conditions, the potentially compounded effects of comorbidity on brain structure have seldom been rigorously assessed.
METHODS: To determine the compounding effect of schizophrenia and alcoholism on regional brain volumes, we performed retrospective quantitative analysis of magnetic resonance images from men who participated in research protocols at the Veterans Affairs Palo Alto Health Care System, Palo Alto, Calif. Participants were selected on the basis of diagnostic criteria, yielding 4 comparison groups: 35 men comorbid for DSM-III-R schizophrenia or schizoaffective disorder and lifetime alcohol abuse or dependence; 64 men with DSM-III-R schizophrenia or schizoaffective disorder; 62 men with Research Diagnostic Criteria alcoholism; and 62 healthy men screened to exclude any Axis I diagnosis or heavy alcohol use. The comorbid group matched the schizophrenia group on age and illness severity but was younger and drank 5 times less alcohol in their lifetimes than the alcoholism group. Gray and white matter volumes from 6 cortical regions were expressed as age- and head size-corrected z scores and were subjected to multivariate profile analyses.
RESULTS: Gray matter volume deficits were present in all 3 patient groups but were greatest in the comorbid group. In the comorbid group, the most prominent volume deficits were in the prefrontal and anterior superior temporal regions.
CONCLUSIONS: Despite lower alcohol exposure than in pure alcoholism, the comorbidity of schizophrenia with alcoholism has a particularly profound effect on prefrontal gray matter volume, compounding the prominent prefrontal deficits present independently in schizophrenia and alcoholism.

Entities:  

Mesh:

Year:  2003        PMID: 12622657     DOI: 10.1001/archpsyc.60.3.245

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  33 in total

1.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

Review 2.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 3.  Structural cerebral variations as useful endophenotypes in schizophrenia: do they help construct "extended endophenotypes"?

Authors:  Konasale M Prasad; Matcheri S Keshavan
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

Review 4.  [Frontal brain volume reduction due to antipsychotic drugs?].

Authors:  V Aderhold; S Weinmann; C Hägele; A Heinz
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

5.  Reduced dendritic spine density in auditory cortex of subjects with schizophrenia.

Authors:  Robert A Sweet; Ruth A Henteleff; Wei Zhang; Allan R Sampson; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2008-05-07       Impact factor: 7.853

6.  Impact of substance use disorder on gray matter volume in schizophrenia.

Authors:  Margaret Quinn; Maureen McHugo; Kristan Armstrong; Neil Woodward; Jennifer Blackford; Stephan Heckers
Journal:  Psychiatry Res Neuroimaging       Date:  2018-08-03       Impact factor: 2.376

Review 7.  Neuroimaging Studies in Patients With Mental Disorder and Co-occurring Substance Use Disorder: Summary of Findings.

Authors:  Kaloyan Rumenov Stoychev
Journal:  Front Psychiatry       Date:  2019-10-23       Impact factor: 4.157

8.  Biologic Commonalities between Mental Illness and Addiction.

Authors:  Karen J Hartwell; Bryan K Tolliver; Kathleen T Brady
Journal:  Prim psychiatry       Date:  2009-08-01

Review 9.  Clinical and pathological features of alcohol-related brain damage.

Authors:  Natalie M Zahr; Kimberley L Kaufman; Clive G Harper
Journal:  Nat Rev Neurol       Date:  2011-04-12       Impact factor: 42.937

Review 10.  Auditory dysfunction in schizophrenia: integrating clinical and basic features.

Authors:  Daniel C Javitt; Robert A Sweet
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.